Tags

Type your tag names separated by a space and hit enter

The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.
Clin Infect Dis. 2006 Nov 01; 43(9):1089-134.CI

Abstract

Evidence-based guidelines for the management of patients with Lyme disease, human granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and babesiosis were prepared by an expert panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 31[Suppl 1]:1-14). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. For each of these Ixodes tickborne infections, information is provided about prevention, epidemiology, clinical manifestations, diagnosis, and treatment. Tables list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease and provide a partial list of therapies to be avoided. A definition of post-Lyme disease syndrome is proposed.

Authors+Show Affiliations

Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY 10595, USA. Gary_Wormser@nymc.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

17029130

Citation

Wormser, Gary P., et al. "The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines By the Infectious Diseases Society of America." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 43, no. 9, 2006, pp. 1089-134.
Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-134.
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J. S., & Nadelman, R. B. (2006). The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 43(9), 1089-134.
Wormser GP, et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines By the Infectious Diseases Society of America. Clin Infect Dis. 2006 Nov 1;43(9):1089-134. PubMed PMID: 17029130.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. AU - Wormser,Gary P, AU - Dattwyler,Raymond J, AU - Shapiro,Eugene D, AU - Halperin,John J, AU - Steere,Allen C, AU - Klempner,Mark S, AU - Krause,Peter J, AU - Bakken,Johan S, AU - Strle,Franc, AU - Stanek,Gerold, AU - Bockenstedt,Linda, AU - Fish,Durland, AU - Dumler,J Stephen, AU - Nadelman,Robert B, Y1 - 2006/10/02/ PY - 2006/08/21/received PY - 2006/08/21/accepted PY - 2006/10/10/pubmed PY - 2006/10/19/medline PY - 2006/10/10/entrez SP - 1089 EP - 134 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin. Infect. Dis. VL - 43 IS - 9 N2 - Evidence-based guidelines for the management of patients with Lyme disease, human granulocytic anaplasmosis (formerly known as human granulocytic ehrlichiosis), and babesiosis were prepared by an expert panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 31[Suppl 1]:1-14). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. For each of these Ixodes tickborne infections, information is provided about prevention, epidemiology, clinical manifestations, diagnosis, and treatment. Tables list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease and provide a partial list of therapies to be avoided. A definition of post-Lyme disease syndrome is proposed. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/17029130/full_citation L2 - https://academic.oup.com/cid/article-lookup/doi/10.1086/508667 DB - PRIME DP - Unbound Medicine ER -